INNO-GENE SA ZY -10 (WQ3) — Free Cash Flow Generation Index

Latest as of June 2025: -11.04x

INNO-GENE SA ZY -10 (WQ3) has a Free Cash Flow Generation Index of -11.04x as of June 2025. Free cash flow of €-596.00K represents -11% of operating cash flow (€54.00K). Explore how much does INNO-GENE SA ZY -10 reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-11.04x
Free Cash Flow / Operating CF

Free Cash Flow

€-596.00K
EUR

Operating Cash Flow

€54.00K
EUR

Capital Expenditures

€650.00K
EUR

INNO-GENE SA ZY -10 Free Cash Flow Generation Index (2021–2022)

Historical FCF Generation Index trend for INNO-GENE SA ZY -10 across 2 annual periods. For the full cash flow conversion analysis, see WQ3 operating cash flow.

Annual Free Cash Flow Generation for INNO-GENE SA ZY -10 (2021–2022)

Year-by-year Free Cash Flow Generation Index for INNO-GENE SA ZY -10. Check WQ3 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2022 1.00x €11.00K €11.00K €0.00 ▲ +1.2%
2021 0.99x €6.67 Million €6.75 Million €82.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).